When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Histoplasmosis

Última revisão: 23 Sep 2025
Última atualização: 19 Aug 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • exposure to fungal spores
  • risk factors that impair host defenses
  • fever
  • headache
  • dyspnea
  • dry or nonproductive cough
  • pleuritic chest pain
  • anorexia
  • productive cough
Detalhes completos

Outros fatores diagnósticos

  • abdominal pain
  • fatigue
  • malaise
  • arthralgias
  • weight loss
  • hepatosplenomegaly
  • scattered crackles on chest auscultation
  • bronchial breathing on chest auscultation
  • distant breath sounds on chest auscultation
  • hemoptysis
  • meningitis-like symptoms
  • skin lesions
  • gastrointestinal symptoms
  • sepsis-like syndrome
Detalhes completos

Fatores de risco

  • exposure to fungus
  • emphysema
  • HIV infection
  • treatment with tumor necrosis factor (TNF)-alpha antagonists
  • treatment with corticosteroids
  • treatment with immunosuppressants
  • neutropenia
  • stem cell and solid organ transplant
  • graft-versus-host disease
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • chest x-ray
  • culture
  • antigen testing
  • serology (immunodiffusion precipitin test)
  • serology (complement fixation assay)
  • serology (enzyme immunoassay)
  • CT scan of chest
  • CBC
  • LFTs
Detalhes completos

Investigações a serem consideradas

  • tissue biopsy
Detalhes completos

Algoritmo de tratamento

AGUDA

latent asymptomatic disease (nonpregnant)

acute pulmonary disease (nonpregnant)

chronic pulmonary disease (nonpregnant)

disseminated disease (nonpregnant)

mediastinal granuloma (nonpregnant)

mediastinal fibrosis (nonpregnant)

broncholithiasis (nonpregnant)

pericarditis (nonpregnant)

rheumatologic syndrome (nonpregnant)

meningoencephalitis (nonpregnant)

pregnant

Colaboradores

Autores

Zainab A. Malik, MD, MS, FAAP

Consultant

Pediatrics and Pediatric Infectious Diseases

Mediclinic City Hospital

Dubai

United Arab Emirates

Declarações

ZAM has received speakers' honoraria from Merck-MSD.

David L. Goldman, MD

Associate Professor

Pediatric Infectious Diseases

The Children's Hospital at Montefiore

New York

NY

Declarações

DLG declares that he has no competing interests.

Revisores

Kassem Hammoud, MD

Associate Professor

Division of Infectious Diseases

University of Kansas Health System

Kansas City

MI

Declarações

KH declares that he has no competing interests.

Adriana M. Rauseo, MD

Assistant Professor of Medicine

Division of Infectious Diseases

Department of Internal Medicine

Washington University in St Louis

St Louis

MI

Declarações

AMR declares that she has no competing interests.

Paul Roberts, MD

Assistant Professor

Family Medicine

Mayo Clinic

Jacksonville

FL

Declarações

PR declares that he has no competing interests.

Janak Koirala, MD

Associate Professor of Medicine

Division of Infectious Diseases

Department of Internal Medicine

Southern Illinois University School of Medicine

Springfield

IL

Declarações

JK declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Oct 1;45(7):807-25.Texto completo  Resumo

Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74.Texto completo  Resumo

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and the Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: histoplasmosis. Oct 2024 [internet publication].Texto completo

Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Histoplasmosis images
  • Diagnósticos diferenciais

    • Community-acquired pneumonia
    • Pneumocystis jirovecii pneumonia (PCP)
    • Pulmonary tuberculosis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: histoplasmosis​
    • Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal